StonvexLoading…
StonvexStonvexStonvexCore line items from KEEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $229.28M | $133.27M | $120.40M |
Operating Income | $-149.60M | $-28.01M | $-50.00M |
Net Income | $-284.54M | $-28.36M | $-55.51M |
EPS (Diluted) | $-0.52 | $-0.07 | $-0.21 |
Total Assets | $1.30B | $663.13M | $378.73M |
Total Liabilities | $735.97M | $51.99M | $83.96M |
Cash & Equivalents | $630.96M | $59.54M | $84.04M |
Free Cash Flow OCF − CapEx | $-326.89M | $-428.63M | $-155.32M |
Shares Outstanding | 601.58M | 479.33M | 334.15M |